|Table of Contents|

Study on Maikeluo Pharmacy Prevention for the ‘Xuxiang’ Kiwifruit Cancer Disease

《北方园艺》[ISSN:1001-0009/CN:23-1247/S]

Issue:
2020年05
Page:
34-39
Research Field:
Publishing date:

Info

Title:
Study on Maikeluo Pharmacy Prevention for the ‘Xuxiang’ Kiwifruit Cancer Disease
Author(s):
GUO Huihui1; 2; WANG Pengchao2; LI Yongwu2; LEI Yushan1; 3; SUO Jiangtao1; 2; 3; XU Ming1
(1.Shaanxi Rural Science and Technology Development Center，Xi′an，Shaanxi 710054；2.Shaanxi Bairui Kiwifruit Research Institute Co.Ltd.，Xi′an，Shaanxi 710054；3.Shaanxi Kiwifruit Engineering Technology Research Center，Xi′an，Shaanxi 710054)
Keywords:
kiwifruit cancer disease; incidence rate; incidence index
PACS:
-
DOI:
10.11937/bfyy.20192230
Abstract:
Using the three kinds of medicinal products of Kasugamycin,Kasumin,Kasugamycin，produced by Shaanxi ‘Microbe’ Co.Ltd.,in the ‘Xuxiang’ kiwifruit orchard with 80% kiwifruit cancer disease incidence rate，using tree spraying method to carry out field efficacy test of disease for 3 consecutive years，the effects of three reagents on ‘Xuxiang’ kiwifruit cancer disease were studied,for provide technical support for effective prevention and treatment of kiwifruit cancer.The results showed that after the use of the reagents in 2017，the incidence rate was reduced by 2%-3% compared with before use，and the control increased by 7%.The incidence index of the Kasugamycin treatment decreased by 2.8%，the effect was the most significant，while the incidence index of the control increased by 0.5 percentage point.The incidence rate in 2018 was significantly lower than that in 2017，and the control was 6-8 percentage points higher than that of the treatment rate of using pesticides.The incidence index in 2018 was lower than that before the test in 2017，in which the Kasugamycin treatment was reduced by 2.8%，the treatment of Kasumin and Kasugamycini was decreased by 1.9%，the control treatment was increased by 0.1%.In 2019，the incidence rate increased than 2018，and the Kasugamycin treatment increased by 13%.The Kasumin，Kasugamycin increased by 21% to 24%，and the control increased by more than 30%.It was significantly lower than that in 2017，in which the Kasugamycin treatment was reduced by 44% compared with 2017，and the treatment of Kasumin,Kasugamycin was reduced by 33%-34% compared with 2017，and the control was reduced by 25% compared with 2017.In 2019，the incidence index of Kasugamycin treatment decreased by 3.7% compared with that before the test in 2017，the treatment of Kasumin decreased by 2.1%，the treatment of Kasugamycin decreased by 2.7%，and the control treatment increased by 1.7%.After using the ‘Microbe’ series for three consecutive years，the treatment of ‘Xuxiang’ kiwifruit had a significantly lower incidence than that of the control cancer disease，and the incidence index was reduced to varying degrees.

References:

[1]黄宏文.猕猴桃属分类资源驯化栽培[M].北京:科学出版社,2013.[2]黄其玲,高小宁,赵志博,等.GFPuv标记猕猴桃溃疡病菌的生物学特性及其在土壤、根系中的定殖[J].中国农业科学，2013,46(2):282-291.[3]秦虎强,赵志博,高小宁,等.猕猴桃细菌性溃疡病菌对17种杀菌剂的敏感性及不同药剂田间防效[J].西北农业学报,2015,24(9):145-151.[4]张峰,陈志杰,张淑莲,等.猕猴桃溃疡病药剂防治技术研究[J].西北农林科技大学学报(自然科学版),2005,33(3):71-75.[5]龙友华,夏锦书.猕猴桃溃疡病防治药剂室内筛选及田间药效试验[J].贵州农业科学,2010,38(10)：84-86.[6]高蓬明,王瑞,马立志.猕猴桃溃疡病防治药剂的室内毒力及田间防治效果[J].贵州农业科学,2013,41(4):85-88.[7]SEＲIZAWA S,ICHIKAWA T.Epidemiology of bacterial canker of kiwifruit[J].Annual Meeting of the Phytopathological Society of Japan,1993,59:460-468.[8]李黎,钟彩虹,李大卫.猕猴桃细菌性溃疡病的研究进展[J].华中农业大学学报,2013,32(5):124-133.

Memo

Memo:
-
Last Update: 2020-04-23